Skip to main content
Fig. 3 | Diabetology & Metabolic Syndrome

Fig. 3

From: Impact of sodium–glucose cotransporter 2 inhibitors on renal function in participants with type 2 diabetes and chronic kidney disease with normoalbuminuria

Fig. 3

Rates of change in estimated glomerular filtration rate (eGFR) at 2 years after starting sodium–glucose cotransporter 2 (SGLT2) inhibitor (%∆eGFR + 2y) in participants with type 2 diabetes and chronic kidney disease in three groups: normoalbuminuria (A1; n = 46), microalbuminuria (A2; n = 25), and macroalbuminuria (A3; n = 16). *P < 0.05 between A1 and A3 group, one-way analysis of variance followed by post hoc Bonferroni test

Back to article page

Diabetology & Metabolic Syndrome

ISSN: 1758-5996

Contact us